GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Samjin Pharmaceutical Co Ltd (XKRX:005500) » Definitions » Ending Cash Position

Samjin Pharmaceutical Co (XKRX:005500) Ending Cash Position : ₩9,210 Mil (As of Jun. 2024)


View and export this data going back to 1988. Start your Free Trial

What is Samjin Pharmaceutical Co Ending Cash Position?

Samjin Pharmaceutical Co's Ending Cash Position for the quarter that ended in Jun. 2024 was ₩9,210 Mil.

Samjin Pharmaceutical Co's quarterly Ending Cash Position increased from Dec. 2023 (₩2,401 Mil) to Mar. 2024 (₩5,802 Mil) and increased from Mar. 2024 (₩5,802 Mil) to Jun. 2024 (₩9,210 Mil).

Samjin Pharmaceutical Co's annual Ending Cash Position declined from Dec. 2021 (₩7,941 Mil) to Dec. 2022 (₩2,341 Mil) but then increased from Dec. 2022 (₩2,341 Mil) to Dec. 2023 (₩2,401 Mil).

Samjin Pharmaceutical Co Ending Cash Position Historical Data

The historical data trend for Samjin Pharmaceutical Co's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Samjin Pharmaceutical Co Ending Cash Position Chart

Samjin Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 31,895.62 18,909.48 7,940.72 2,341.45 2,401.47

Samjin Pharmaceutical Co Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2,823.11 2,398.09 2,401.47 5,802.47 9,210.47

Samjin Pharmaceutical Co Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Samjin Pharmaceutical Co's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=2341.418+60.056
=2,401

Samjin Pharmaceutical Co's Ending Cash Position for the quarter that ended in Jun. 2024 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=5802.466+3408.002
=9,210

Samjin Pharmaceutical Co Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Samjin Pharmaceutical Co's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Samjin Pharmaceutical Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Samjin Pharmaceutical Co Ltd (XKRX:005500) » Definitions » Ending Cash Position
Comparable Companies
XKRX:092040 XKRX:000020 XKRX:058820 XKRX:102460 XKRX:084110 XKRX:007570 XKRX:001630 XKRX:102940 XKRX:008490 XKRX:096760 ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
N/A
Address
121, Wausan-ro, Mapo-Ku, Seoul, KOR, 121-837
Website
https://www.samjinpharm.co.kr
Samjin Pharmaceutical Co Ltd is a part of the healthcare sector in Korea. The company functions as a pharmaceutical product manufacturer addressing severe diseases such as osteoporosis, hepatitis, respiratory and gastrointestinal diseases. Its suite of products includes capsules, syringes, injection medicines, and solvents.

Samjin Pharmaceutical Co Headlines

No Headlines